Tech & industry
A brain implant detected walking in people with Parkinson's at home with more than 95 per cent accuracy, a study has found. Researchers said the findings could help pave the way for more personalised and responsive therapies for Parkinson's, which is caused by the loss of nerve cells that produce dopamine, a chemical involved in [...]
By Tuned Global Music in the medicine and research space has proved to have significant therapeutic benefits, treating conditions including dementia, Parkinson’s disease, PTSD and ADHD. Now, with the evolution of music technology and AI, the potential to heal the mind through music has become even more powerful. At a recent industry event, three experts [...]
An oral therapy for Huntington's disease has been deemed eligible for a fast-track approval pathway by Australia's medicines regulator. The therapy, SKY-0515, is a small molecule designed to target RNA, the genetic instructions cells use to produce proteins involved in the disease. Huntington's disease is a rare inherited neurodegenerative disorder that causes progressive damage to [...]
Clee Medical has secured seed funding to advance real-time brain imaging for use in stereotactic neurosurgery. The financing will support development and clinical validation of the company’s Neuro Access platform, a minimally invasive technology designed to enable real-time visualisation of brain anatomy during surgery. Founded in October 2024 by Matt Lapinski and Abed [...]
An Australian study is exploring VR for safe fall recovery among people with spinal cord injury. The University of Queensland is leading the project, which is developing a virtual reality programme to help patients practise safe falls for the first time. The work builds on seven years of research into spinal cord injury and falls [...]
Nyra health has raised €20m in a Series A round to expand its AI-based neurorehab platform across Europe and the US. The Vienna-based company said it will use the funding to expand its technology platform in the DACH region, accelerate its US expansion and pursue its aim of setting a new standard for data-driven neurorehabilitation. [...]
An epilepsy drug firm has secured US$2.4m in grant funding to expand its precision medicines platform for neurological disorders. Lario Therapeutics is developing selective small-molecule inhibitors targeting voltage-gated neuronal calcium channels, proteins that regulate calcium flow into nerve cells and are central to brain signalling. The funding will support work in Parkinson’s disease and exploration [...]
Investment in UK neurotechnology studies has doubled since 2024, now making up around a quarter of all clinical investigation applications, according to the medicines regulator. New MHRA figures show a 17 per cent rise in approved clinical investigations compared with last year, with companies increasingly choosing Great Britain to test new health technologies. Clinical investigations [...]
Immunic has closed a private placement raising US$200m upfront to fund MS drug trials, with the financing aimed at advancing late-stage studies in multiple sclerosis. The biotechnology company said the deal could provide up to a further US$200m if additional warrants are exercised. Immunic issued just over 229m pre-funded warrants priced at US$0.873 each, generating [...]
A New Zealand medtech developing a portable scanner to detect stroke at the bedside has raised NZ$7.28m (A$6.2m) in a first close of its pre-Series A round. Wellumio is developing a portable neuroimaging device designed to enable rapid, point-of-care stroke detection, when early treatment can improve outcomes. The technology, called Axana, aims to identify acute [...]
